Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain

Blood (2024) 144 (Supplement 1): 2555.

https://doi.org/10.1182/blood-2024-202555

Published: 2024

Journal Articles

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Blood (2024) 144 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2024-197940

Published: 2024

Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón

Blood (2024) 144 (6): 646–656.

https://doi.org/10.1182/blood.2024024250

Published: 2024

Journal Articles

Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)

Blood (2019) 134 (Supplement_1): 4580.

https://doi.org/10.1182/blood-2019-129880

Published: 2019

Journal Articles

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?

Alba Nydia Ramirez Lopez, MD, Enrique Baez De La Fuente, MD, Rosa Elva De Leon Cantu, MD, Diego Cruz Contreras, MD, Jose Alfredo Carrizalez Villarreal, MD, Jose Luis Cedillo De La Cerda, Roxana Saldaña Vazquez, MD, Helga Patricia Sorkee Davila, MD, Axel Eduardo Rosas Rodríguez, MD, Severiano Baltazar Arellano, MD, Roberto Hernandez Valdes, MD, Bernardo Lafarga Amao, RESIDENTE, Rosa Lozano, MD, Andrea Terrazas, MD

Blood (2017) 130 (Supplement 1): 5520.

https://doi.org/10.1182/blood.V130.Suppl_1.5520.5520

Published: 2017

Journal Articles

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2015) 126 (23): 4356.

https://doi.org/10.1182/blood.V126.23.4356.4356

Published: 2015

Journal Articles

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

Veronica Gonzalez de la Calle, MD, Ramon Garcia-Sanz, Eduardo Sobejano, Enrique M. Ocio, MD PhD, Noemi Puig, MD PhD, Norma Carmen Gutierrez, PhD MD, Alberto Melón, MD, Joaquin Gonzalez, MD, Alfonso Garcia de Coca, MD, Jose M. Hernandez, MD, Roberto Hernandez, MD, Abelardo Barez, MDPhD, Jose M. Alonso, MD, Carmen Aguilera, MD, Fernando Escalante, Guillermo Martin, MD, Rosa Lopez, MD, Pilar de la Fuente, MD, Maria-Victoria Mateos, MD PhD

Blood (2014) 124 (21): 3369.

https://doi.org/10.1182/blood.V124.21.3369.3369

Published: 2014

Journal Articles

Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?

Pranavi Ravichandran, BSC, Kris P Croome, MD, Michael J. Kovacs, MD, Roberto Hernandez-Alejandro, MD, Alejandro Lazo-Langner, MD, MSc

Blood (2012) 120 (21): 3390.

https://doi.org/10.1182/blood.V120.21.3390.3390

Published: 2012

Journal Articles

Epidemiological Study and Prognostic Markers in Patients Diagnosed with Chronic Ly Lmphocytic Leukemia. EPIGEN Study.

Mariola Abio, Gonzalo Caballero, Francisco Sala, Guillermina Hurtado, Jose A Marquez, Victoria Dourdil, Susana Arambarri, Filomena Floristan, Nicolas Gonzalez, Roberto Hernandez, Luis Lopez, Luis Perdiguer, Javier Marco, Francisco Sancho, Ignacio Olalla, Pilar Giraldo, MD

Blood (2009) 114 (22): 4398.

https://doi.org/10.1182/blood.V114.22.4398.4398

Published: 2009

Journal Articles

Nilotinib (AMN107) Can Induce Complete Cytogenetic Responses (CCyR) and Molecular Responses in Patients (Pts) with Advanced Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib Mesylate (IM). Report of the Compassionate Use Program of Nilotinib in Mexico

Blood (2008) 112 (11): 4275.

https://doi.org/10.1182/blood.V112.11.4275.4275

Published: 2008

Journal Articles

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Jose R. Borbolla Escoboza, MD, Manuel A. Lopez-Hernandez, MD, Marcos E. Garza, MD, Enrique Baez, MD, Elvira Trueba, MD, Roberto Hernandez, MD, Jose E. DeDiego-FloresChapa, MD, Severiano Baltazar, MD, Martha Alvarado, MD, Gerardo Villareal, MD, Mauricio C. Gonzalez-Avante, MD, Rosa E. De Leon, MD, Jose L. Cedillo, MD, Jason A. Penniecook, MD, Yara E. Tovar, MD, Maria I. Leon, Cecilia Ramirez-Assad, MD

Blood (2004) 104 (11): 5015.

https://doi.org/10.1182/blood.V104.11.5015.5015

Published: 2004

Journal Articles

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Blood (2004) 104 (11): 4312.

https://doi.org/10.1182/blood.V104.11.4312.4312

Published: 2004

NARROW

Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?

Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma

Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma

Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?

Epidemiological Study and Prognostic Markers in Patients Diagnosed with Chronic Ly Lmphocytic Leukemia. EPIGEN Study.

Nilotinib (AMN107) Can Induce Complete Cytogenetic Responses (CCyR) and Molecular Responses in Patients (Pts) with Advanced Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib Mesylate (IM). Report of the Compassionate Use Program of Nilotinib in Mexico

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only